AzTrials
AzTrials

Disease OutbreaksPREDAFLUNCT02858531

Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics

An observational study of Disease Outbreaks and Child, run by Centre Hospitalier Universitaire de Saint Etienne at 11 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Epidemics and infectious diseases in general, punctuate much of the activity of an emergency service. The impact of winter infections is particularly important to vulnerable populations such as infant during bronchiolitis epidemics and the elderly during seasonal influenza. Read more about this study

Who is it for?
Ages 1 month and older
Conditions the study is for
Disease Outbreaks, Child, Elderly
What is being tested?
data retrieval
How many people
760,000 participants
Where
11 sitesFrance
Study dates
1 Sep 2016to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: child < 24 months with bronchiolitis or elderly < 60 years with acute renal failure

Who may be able to join

  • child < 24 months with bronchiolitis
  • elderly < 60 years with acute renal failure or breathing problem

Who cannot join

  • refuse of transmission of their data

Trial locations and contacts

11 sites in 1 country.

11 sites in 1 country

France11 sites
  • CHU de Grenoble (adult emergency service)

    Grenoble, 38000

  • CHU de Grenoble (pediatric service)

    Grenoble, 38000

  • CHU de Lyon (adult emergency service)

    Lyon, 69000

  • CHU de Lyon (laboratory of virology)

    Lyon, 69000

  • CHU de Lyon HFME (pediatric service)

    Lyon, 69000

  • CHU de Saint Etienne (adult emergency service)

    Saint-Etienne, 42055

  • CHU de Saint Etienne (Pediatric service)

    Saint-Etienne, 42055

  • CH de Valence (adult emergency service)

    Valence, 26000

  • CH de Valence (pediatric service)

    Valence, 26000

  • CH de Villefranche (adult emergency service)

    Villefranche-sur-Saône, 69655

  • CH de Villefranche (pediatric service)

    Villefranche-sur-Saône, 69655

Other trials in France

About this study

Epidemics and infectious diseases in general, punctuate much of the activity of an emergency service. The impact of winter infections is particularly important to vulnerable populations such as infant during bronchiolitis epidemics and the elderly during seasonal influenza. Each year, these epidemic phenomena lead to disorganization of emergency services and healthcare teams by lack of anticipation and organizational measures in particular to manage the approval of emergency services for the most vulnerable populations requiring hospitalization.

For 2 years, the pediatric emergency department of St Etienne University Hospital has a decision support tool for the periods of winter epidemics. Through a retrospective analysis of Passages of Emergency summary, this tool provides an estimate of infants with bronchiolitis flow day to day, and the availability in real time of an abnormally high flow of patients to pediatric emergencies. These data can help to affirm that the epidemic begins in this hospital.

Being tested
data retrieval
Medical subject headings
Bronchiolitis, Acute Kidney Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • data retrievalOther

    data retrieval with the Hospital Information System

Study groups in NCT02858531
Study groupRoleWhat they receive
patients < 24 months or 60 years with bronchiolitis or ARFARF = Acute Renal Failure
Receives: Other: data retrieval

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. build a predictive tool

    a tool with different levels of alerts of the influx of people aged to emergencies during winter epidemics.

    Variables in the model : activity database in emergency services, computer data, virology database and average length of stay.

    Measured: at inclusion

Secondary outcomes (4)
  1. Difference between the estimated date and the effective date of the activity peak on the average length of stay of patients in the hospital of Saint Etienne

    Measured: at inclusion

  2. Difference between the estimated date and the effective date of the activity peak on the average length of stay of patients in the other hospitals

    Measured: at inclusion

  3. Comparison virological databases with clinical diagnosis of patients

    Measured: at inclusion

  4. Percentage of elderly staying more than 10 hours in the emergency services.

    Measured: at inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2016 (estimated)
  2. Study start1 Sep 2016
  3. Primary completion31 Dec 2023
  4. Study completion31 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
760,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02858531
Sponsor's protocol ID
1508191
Other IDs
1969303 v 0
Acronym
PREDAFLU
Status last verified
Mar 2024
First submitted
1 Aug 2016
Last updated
22 Mar 2024
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Disease Outbreaks and Child, run by Centre Hospitalier Universitaire de Saint Etienne at 11 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 11 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

build a predictive tool (time frame: at inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Mar 2024; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in